{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Free Realtime Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "SEK", "regularMarketChangePercent": -2.4226089, "regularMarketPrice": 7.25, "earningsTimestamp": 1620125940, "earningsTimestampStart": 1620125940, "earningsTimestampEnd": 1620125940, "trailingAnnualDividendRate": 0.0, "trailingPE": 1.9808743, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": 3.66, "sharesOutstanding": 19801200, "bookValue": 7.682, "fiftyDayAverage": 7.0533, "fiftyDayAverageChange": 0.1967001, "fiftyDayAverageChangePercent": 0.02788767, "twoHundredDayAverage": 8.25815, "twoHundredDayAverageChange": -1.0081501, "twoHundredDayAverageChangePercent": -0.12207941, "marketCap": 148582224, "priceToBook": 0.9437646, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1432537200000, "priceHint": 2, "marketState": "REGULAR", "exchange": "STO", "shortName": "Combigene AB", "longName": "CombiGene AB (publ)", "messageBoardId": "finmb_272213430", "exchangeTimezoneName": "Europe/Stockholm", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "se_market", "esgPopulated": false, "regularMarketChange": -0.17999983, "regularMarketTime": 1684143808, "regularMarketDayHigh": 7.69, "regularMarketDayRange": "7.21 - 7.69", "regularMarketDayLow": 7.21, "regularMarketVolume": 5021, "regularMarketPreviousClose": 7.43, "bid": 7.13, "ask": 7.36, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stockholm", "financialCurrency": "SEK", "regularMarketOpen": 7.43, "averageDailyVolume3Month": 34955, "averageDailyVolume10Day": 43410, "fiftyTwoWeekLowChange": 0.8699999, "fiftyTwoWeekLowChangePercent": 0.13636361, "fiftyTwoWeekRange": "6.38 - 10.55", "fiftyTwoWeekHighChange": -3.3000002, "fiftyTwoWeekHighChangePercent": -0.31279624, "fiftyTwoWeekLow": 6.38, "fiftyTwoWeekHigh": 10.55, "symbol": "COMBI.ST"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "Agavagen 52A", "city": "Liding\u00f6", "zip": "181 55", "country": "Sweden", "phone": "46 7 04 66 31 63", "website": "https://www.combigene.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "CombiGene AB (publ) engages in the development of gene therapy for severe life-altering diseases in Sweden. The company is developing two gene therapy candidates, including CG01, which is in preclinical studies for the treatment of epilepsy and biodistribution and toxicology studies; and CGT2 for the treatment of lipodystrophy. The company has a licensing and collaboration agreement with Lipigon Pharmaceuticals AB to develop a gene therapy treatment for partial lipodystrophy; and with Spark Therapeutics to develop adeno-associated virus (AAV) based gene therapies. CombiGene AB (publ) was founded in 1999 and is headquartered in Liding\u00f6, Sweden.", "fullTimeEmployees": 11, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jan  Nilsson", "age": 73, "title": "Chief Exec. Officer", "yearBorn": 1949, "fiscalYear": 2022, "totalPay": {"raw": 2590515, "fmt": "2.59M", "longFmt": "2,590,515"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Associate Prof. David  Woldbye", "age": 59, "title": "Scientific Founder", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Merab  Kokaia Ph.D.", "age": 66, "title": "Scientific Founder", "yearBorn": 1956, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Louise  Aspenberg", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1976, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Peter  Ekolind", "age": 58, "title": "Chief Operating Officer", "yearBorn": 1964, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Karin  Agerman", "age": 49, "title": "Chief Scientific Officer", "yearBorn": 1973, "fiscalYear": 2018, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}